Apostle Inc

Apostle Inc. is a private, commercial-stage diagnostics company headquartered in San Jose, California, that has established itself as a specialized provider of liquid biopsy solutions. The company's business model integrates the sale of proprietary reagent kits (e.g., MiniMax for cfDNA), laboratory instruments (including ultra-low temperature freezers), and fee-for-service laboratory offerings such as cfDNA isolation and clinical trial support. With a clear focus on the growing liquid biopsy market, Apostle's technology platform aims to improve the sensitivity and efficiency of nucleic acid extraction, positioning it as an enabler for next-generation sequencing (NGS), digital PCR, and other advanced diagnostic applications in oncology and beyond.

A suite of proprietary technologies for nucleic acid isolation and preparation, including MiniMax (cfDNA/cfRNA), MagTouch (magnetic bead purification), BCT (blood collection tubes), MiniEnrich (purification & size selection), and MiniGenomics (genomic DNA/RNA). Focus on preserving short, fragile fragments critical for liquid biopsy applications.

Apostle competes in the crowded nucleic acid extraction and liquid biopsy sample prep market against giants like Qiagen, Thermo Fisher Scientific, and Roche, as well as many specialized startups. Its differentiation hinges on claimed superior performance for short-fragment cfDNA/cfRNA isolation and a vertically integrated product-service portfolio.